Erasca, Inc. (ERAS)
16.37
-0.39
(-2.33%)
USD |
NASDAQ |
Sep 02, 16:00
16.31
-0.06
(-0.37%)
Pre-Market: 08:13
Erasca Net Income (Annual) : -124.55M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -124.55M |
| December 31, 2024 | -161.65M |
| December 31, 2023 | -125.04M |
| December 31, 2022 | -242.80M |
| Date | Value |
|---|---|
| December 31, 2021 | -122.76M |
| December 31, 2020 | -101.66M |
| December 31, 2019 | -12.04M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Revolution Medicines, Inc. | -1.131B |
| Tango Therapeutics, Inc. | -101.59M |
| Cogent Biosciences, Inc. | -328.94M |
| Apogee Therapeutics, Inc. | -255.84M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |